Richard Baker, MD
Otolaryngology · Oklahoma City, OKNPI 1588761654
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $16,556 of the $17,485 with a category attached, or 94.7%. Cochlear Americas accounts for 99.4% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $16,927, more than ten times the $165 reported in 2019. Among otolaryngology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $1248.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cochlear Americas$17K
- TELA Bio, Inc.$54
- Stryker$21
- Med-el Corporation$19
- Arbor Pharmaceuticals, Inc.$12
What the payments were for
- Travel & lodging$16,55695%
- Food & beverage$9295%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cochlear Americas | 10 | $17,379 |
| TELA Bio, Inc. | 1 | $54 |
| Stryker | 1 | $21 |
| Med-el Corporation | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Baha$17,189
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$17,058
- OSIA OSI300 IMPLANT$17,058
- Nucleus$131
How this compares
$17,485 in reported general payments places this provider in the 95th percentile of 109 otolaryngology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 88 | $813 |
| Ipratropium Bromide | 17 | $379 |
| Mometasone Furoate | 20 | $295 |
| Methylprednisolone | 34 | $257 |
| Ofloxacin | 13 | $185 |
| Furosemide | 12 | $112 |
| Prednisone | 19 | $89 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $36 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Oklahoma City
- Kibwei McKinneyOklahoma City$315K
- Edward El RassiOklahoma City$13K
- Benjamin CollinsOklahoma City$10K
- Keith ClarkOklahoma City$6K
- Rachad MhawejOklahoma City$6K
- John HouckOklahoma City$5K
- Matthew SharumOklahoma City$5K
- Hassan HawsawiOklahoma City$5K
- Brandon PiersonOklahoma City$5K
- Colby McLaurinOklahoma City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.